Skip to main content
. 2015 Jun 5;132(Suppl 199):11–19. doi: 10.1111/ane.12425

Figure 5.

Figure 5

The proportion of early MS patients (RRMS with <15 years of duration) currently on disease-modifying drugs (DMDs) in Sweden (‘RIKET’) and in the 21 counties of Sweden. Gray bars show the proportion of patients on treatment in the registry, whereas green bars show the proportion of the estimated prevalent patient numbers in each county. Graphics are generated in real time from registry data using the Visualization and Analysis platform (VAP).